Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: implications for the development of isocitrate lyase inhibitors as novel antimicrobials.
about
Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicansInhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agentsPresent and future therapeutic strategies for melioidosis and glanders.Stable, site-specific fluorescent tagging constructs optimized for burkholderia species.Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species.Evaluation of surrogate animal models of melioidosisOxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome.Novel type II and monomeric NAD+ specific isocitrate dehydrogenases: phylogenetic affinity, enzymatic characterization, and evolutionary implication.Role of Alanine Dehydrogenase of Mycobacterium tuberculosis during Recovery from Hypoxic Nonreplicating Persistence.The unexpected discovery of a novel low-oxygen-activated locus for the anoxic persistence of Burkholderia cenocepaciaLethal Consequences of Overcoming Metabolic Restrictions Imposed on a Cooperative Bacterial PopulationThe art of persistence-the secrets to Burkholderia chronic infections.Food Fight: Role of Itaconate and Other Metabolites in Antimicrobial Defense.Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin.Bacterial itaconate degradation promotes pathogenicity.Burkholderia pseudomallei kills Caenorhabditis elegans through virulence mechanisms distinct from intestinal lumen colonization.Melioidosis requires better data sharing for improved diagnosis and management in the Mekong region.GvmR - A Novel LysR-Type Transcriptional Regulator Involved in Virulence and Primary and Secondary Metabolism of Burkholderia pseudomallei.
P2860
Q26801524-57E809E5-2EC1-4495-842F-AF17073CE88FQ28538283-1CF122BB-B05C-4951-985F-CC2BE9ED1C8CQ33797791-8542C660-30C9-4BE5-8FEF-7555BBEE5766Q34290270-ABC7A06B-2416-4707-A1B1-0695896DFE74Q34630198-9E5C52DA-55C3-4898-8607-DE7E79542244Q35028834-FE074A53-88D6-42AF-ABE4-D61591ECD688Q35123268-2EB5DF0A-6D51-42DB-8105-EC3B4CF10AE3Q35179703-C6D17E46-1992-4B46-B23A-4CB8C2B45FD7Q36023796-66CFA9F0-59BB-4B47-8821-A7C67CEFBD85Q37039711-BAC883EA-9E5F-49DB-A176-AFEA72080AEAQ37695595-135BDD30-1CB6-4836-81E8-4102015EB453Q38839466-3C81FD13-C09E-4E09-836B-98EECA60D4C2Q38954058-C255AD64-4560-4350-AA24-B51733D58ABBQ40211764-6E2682F5-91DE-4668-983B-79A29185E035Q41387636-8980CAAF-A6EB-4D02-8482-171C39984774Q42005058-E764B110-A1F9-4758-BAA7-7FE3B15E4874Q42549682-7D8EF0B5-3223-4998-98D7-7EE4A7D10C91Q55095890-87CCCC51-D961-49CF-9A91-0FC7E429CD98
P2860
Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: implications for the development of isocitrate lyase inhibitors as novel antimicrobials.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Burkholderia pseudomallei isoc ...... itors as novel antimicrobials.
@en
Burkholderia pseudomallei isoc ...... itors as novel antimicrobials.
@nl
type
label
Burkholderia pseudomallei isoc ...... itors as novel antimicrobials.
@en
Burkholderia pseudomallei isoc ...... itors as novel antimicrobials.
@nl
prefLabel
Burkholderia pseudomallei isoc ...... itors as novel antimicrobials.
@en
Burkholderia pseudomallei isoc ...... itors as novel antimicrobials.
@nl
P2093
P2860
P356
P1476
Burkholderia pseudomallei isoc ...... itors as novel antimicrobials.
@en
P2093
Donald E Woods
Erin J van Schaik
Marina Tom
P2860
P304
P356
10.1128/IAI.00609-09
P407
P577
2009-07-20T00:00:00Z